LakeShore Biopharma Co., Ltd. Quarterly Deferred Tax Assets, Net of Valuation Allowance in USD for Q1 2023

Taxonomy & unit
us-gaap: CNY and USD
Description
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
LakeShore Biopharma Co., Ltd. quarterly Deferred Tax Assets, Net of Valuation Allowance history and growth rate for Q1 2023.
  • LakeShore Biopharma Co., Ltd. Deferred Tax Assets, Net of Valuation Allowance for the quarter ending March 31, 2023 was $842K.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 $842K Mar 31, 2023 20-F 2023-07-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.